Producing recombinant therapeutic glycoproteins with enhanced sialylation using CHO-gmt4 glycosylation mutant cells

References

• Hudgin RL, Pricer WE Jr., Ashwell G, Stockert RJ, Morell AG. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J Biol Chem 1974; 249:5536 - 43; PMID: 4370480
   PubMed Web of Science ®Google Scholar
• Morell AG, Gregoriadis G, Scheinberg IH, Hickman J, Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J Biol Chem 1971; 246:1461 - 7; PMID: 5545089
   PubMed Web of Science ®Google Scholar
• Fukuda MN, Sasaki H, Lopez L, Fukuda M. Survival of recombinant erythropoietin in the circulation: the role of carbohydrates. Blood 1989; 73:84 - 9; PMID: 2910371
   PubMed Web of Science ®Google Scholar
• Sodetz JM, Pizzo SV, McKee PA. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein. J Biol Chem 1977; 252:5538 - 46; PMID: 301877
   PubMed Web of Science ®Google Scholar
• Batta SK, Rabovsky MA, Channing CP, Bahl OP. Effect of removal of carbohydrate residues upon the half life and in vivo biological activity of human chorionic gonadotropin. Adv Exp Med Biol 1979; 112:749 - 56; http://dx.doi.org/10.1007/978-1-4684-3474-3_84; PMID: 572624
   PubMedGoogle Scholar
• Grabenhorst E, Schlenke P, Pohl S, Nimtz M, Conradt HS. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconj J 1999; 16:81 - 97; http://dx.doi.org/10.1023/A:1026466408042; PMID: 10612409
   PubMed Web of Science ®Google Scholar
• Hossler P, Khattak SF, Li ZJ. Optimal and consistent protein glycosylation in mammalian cell culture. Glycobiology 2009; 19:936 - 49; http://dx.doi.org/10.1093/glycob/cwp079; PMID: 19494347
   PubMed Web of Science ®Google Scholar
• Goh JSY, Zhang P, Chan KF, Lee MM, Lim SF, Song Z. RCA-I-resistant CHO mutant cells have dysfunctional GnT I and expression of normal GnT I in these mutants enhances sialylation of recombinant erythropoietin. Metab Eng 2010; 12:360 - 8; http://dx.doi.org/10.1016/j.ymben.2010.03.002; PMID: 20346410
   PubMed Web of Science ®Google Scholar
• Goh JS, Liu Y, Liu H, Chan KF, Wan C, Teo G, Zhou X, Xie F, Zhang P, Zhang Y, et al. Highly sialylated recombinant human erythropoietin production in large-scale perfusion bioreactor utilizing CHO-gmt4 (JW152) with restored GnT I function. Biotechnol J 2014; 9:100 - 9; http://dx.doi.org/10.1002/biot.201300301; PMID: 24166780
   PubMed Web of Science ®Google Scholar
• Lim SF, Lee MM, Zhang P, Song Z. The Golgi CMP-sialic acid transporter: A new CHO mutant provides functional insights. Glycobiology 2008; 18:851 - 60; http://dx.doi.org/10.1093/glycob/cwn080; PMID: 18713811
   PubMed Web of Science ®Google Scholar
• Zhang P, Chan KF, Haryadi R, Bardor M, Song Z. CHO glycosylation mutants as potential host cells to produce therapeutic proteins with enhanced efficacy. Adv Biochem Eng Biotechnol 2013; 131:63 - 87; http://dx.doi.org/10.1007/10_2012_163; PMID: 23142953
   PubMed Web of Science ®Google Scholar
• Iskratsch T, Braun A, Paschinger K, Wilson IB. Specificity analysis of lectins and antibodies using remodeled glycoproteins. Anal Biochem 2009; 386:133 - 46; http://dx.doi.org/10.1016/j.ab.2008.12.005; PMID: 19123999
   PubMed Web of Science ®Google Scholar
• Song Z. Roles of the nucleotide sugar transporters (SLC35 family) in health and disease. Mol Aspects Med 2013; 34:590 - 600; http://dx.doi.org/10.1016/j.mam.2012.12.004; PMID: 23506892
   PubMed Web of Science ®Google Scholar
• Patnaik SK, Stanley P. Lectin-resistant CHO glycosylation mutants. Methods Enzymol 2006; 416:159 - 82; http://dx.doi.org/10.1016/S0076-6879(06)16011-5; PMID: 17113866
   PubMedGoogle Scholar
• Kumar R, Yang J, Larsen RD, Stanley P. Cloning and expression of N-acetylglucosaminyltransferase I, the medial Golgi transferase that initiates complex N-linked carbohydrate formation. Proc Natl Acad Sci U S A 1990; 87:9948 - 52; http://dx.doi.org/10.1073/pnas.87.24.9948; PMID: 1702225
   PubMed Web of Science ®Google Scholar
• Chen W, Stanley P. Five Lec1 CHO cell mutants have distinct Mgat1 gene mutations that encode truncated N-acetylglucosaminyltransferase I. Glycobiology 2003; 13:43 - 50; http://dx.doi.org/10.1093/glycob/cwg003; PMID: 12634323
   PubMed Web of Science ®Google Scholar
• Zhong X, Cooley C, Seth N, Juo ZS, Presman E, Resendes N, Kumar R, Allen M, Mosyak L, Stahl M, et al. Engineering novel Lec1 glycosylation mutants in CHO-DUKX cells: molecular insights and effector modulation of N-acetylglucosaminyltransferase I. Biotechnol Bioeng 2012; 109:1723 - 34; http://dx.doi.org/10.1002/bit.24448; PMID: 22252477
   PubMed Web of Science ®Google Scholar
• Sealover NR, Davis AM, Brooks JK, George HJ, Kayser KJ, Lin N. Engineering Chinese hamster ovary (CHO) cells for producing recombinant proteins with simple glycoforms by zinc-finger nuclease (ZFN)-mediated gene knockout of mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase (Mgat1). J Biotechnol 2013; 167:24 - 32; http://dx.doi.org/10.1016/j.jbiotec.2013.06.006; PMID: 23777858
   PubMed Web of Science ®Google Scholar
• Reeves PJ, Callewaert N, Contreras R, Khorana HG. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible N-acetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc Natl Acad Sci U S A 2002; 99:13419 - 24; http://dx.doi.org/10.1073/pnas.212519299; PMID: 12370423
   PubMed Web of Science ®Google Scholar
• Opat AS, Puthalakath H, Burke J, Gleeson PA. Genetic defect in N-acetylglucosaminyltransferase I gene of a ricin-resistant baby hamster kidney mutant. Biochem J 1998; 336:593 - 8; PMID: 9841870
   PubMed Web of Science ®Google Scholar
• Zhang P, Tan DL, Heng D, Wang T, Mariati, Yang Y, Song Z. A functional analysis of N-glycosylation-related genes on sialylation of recombinant erythropoietin in six commonly used mammalian cell lines. Metab Eng 2010; 12:526 - 36; http://dx.doi.org/10.1016/j.ymben.2010.08.004; PMID: 20826224
   PubMed Web of Science ®Google Scholar
• Lin N, Davis D, Sealover NR, Mascarenhas J, George HJ, Kayser KJ. Mgat4 May Play a Role in Increased Sialylation by Overexpressing Functional MGAT1 in Mgat1-Disrupted Chinese Hamster Ovary (CHO) Cells. Poster presented at: BioProcess International™ Conference and Exhibition 2013; September 2013; Boston, MA, USA.
   Google Scholar
• Furbish FS, Steer CJ, Krett NL, Barranger JA. Uptake and distribution of placental glucocerebrosidase in rat hepatic cells and effects of sequential deglycosylation. Biochim Biophys Acta 1981; 673:425 - 34; http://dx.doi.org/10.1016/0304-4165(81)90474-8; PMID: 6784774
   PubMed Web of Science ®Google Scholar
• Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE, et al. Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher’s disease. N Engl J Med 1991; 324:1464 - 70; http://dx.doi.org/10.1056/NEJM199105233242104; PMID: 2023606
   PubMed Web of Science ®Google Scholar
• Brumshtein B, Salinas P, Peterson B, Chan V, Silman I, Sussman JL, Savickas PJ, Robinson GS, Futerman AH. Characterization of gene-activated human acid-beta-glucosidase: crystal structure, glycan composition, and internalization into macrophages. Glycobiology 2010; 20:24 - 32; http://dx.doi.org/10.1093/glycob/cwp138; PMID: 19741058
   PubMed Web of Science ®Google Scholar
• Shaaltiel Y, Bartfeld D, Hashmueli S, Baum G, Brill-Almon E, Galili G, Dym O, Boldin-Adamsky SA, Silman I, Sussman JL, et al. Production of glucocerebrosidase with terminal mannose glycans for enzyme replacement therapy of Gaucher’s disease using a plant cell system. Plant Biotechnol J 2007; 5:579 - 90; http://dx.doi.org/10.1111/j.1467-7652.2007.00263.x; PMID: 17524049
   PubMed Web of Science ®Google Scholar
• Van Patten SM, Hughes H, Huff MR, Piepenhagen PA, Waire J, Qiu H, Ganesa C, Reczek D, Ward PV, Kutzko JP, et al. Effect of mannose chain length on targeting of glucocerebrosidase for enzyme replacement therapy of Gaucher disease. Glycobiology 2007; 17:467 - 78; http://dx.doi.org/10.1093/glycob/cwm008; PMID: 17251309
   PubMed Web of Science ®Google Scholar
• Lam JS, Mansour MK, Specht CA, Levitz SM. A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 2005; 175:7496 - 503; http://dx.doi.org/10.4049/jimmunol.175.11.7496; PMID: 16301657
   PubMed Web of Science ®Google Scholar
• Betting DJ, Mu XY, Kafi K, McDonnel D, Rosas F, Gold DP, Timmerman JM. Enhanced immune stimulation by a therapeutic lymphoma tumor antigen vaccine produced in insect cells involves mannose receptor targeting to antigen presenting cells. Vaccine 2009; 27:250 - 9; http://dx.doi.org/10.1016/j.vaccine.2008.10.055; PMID: 19000731
   PubMed Web of Science ®Google Scholar